Craniometaphyseal dysplasia, autosomal dominant (CMDD) Print

Back to All Tests
Order Test
Gene
ANKH
MIM
123000
Clinical Description

Craniometaphyseal dysplasia, autosomal dominant

Craniometaphyseal dysplasia, autosomal dominant (CMDD; MIM 123000) is a sclerosing bone disorder caused by loss of function mutations in the ANKH gene. Progressive thickening of the craniofacial bones leads to sclerosis of the skull base, facial palsy, early-onset hearing loss, obliteration of the sinuses, and malocclusion and crowding of the teeth. Affected individuals typically have normal stature but display undermodeling of the tubular bones and metaphyseal flaring. Autosomal dominant craniometaphyseal dysplasia is allelic to chondrocalcinosis 2 (MIM 118600).

Available Tests
The following test(s) are available for Craniometaphyseal dysplasia, autosomal dominant (CMDD)
DNA Sequencing
Price: $1,340
CPT Codes: 83890 83898 83894 83904 83912
  1 15 15 22 1
Back to All Tests
Order Test

Suggest a Test

Our list of diagnostics continues to expand to meet your needs. Please let us know if you require an additional test by completing our online Suggest a Test form.

Feedback

Comment on our website, let us know how we did on your last test or complete a brief survey. Submit your feedback now.